About Jingfeng

Beijing Jingfeng Pharmaceutical Group Co., Ltd. (Jingfeng Pharma), a wholly-owned subsidiary of Jointown Pharmaceutical Group, builds its business in the production and operation of the pharmaceutical industry, professional incubators and other health industries, generic drug research and development, FDF production (oral solid preparations, external semi-solid preparations, external liquid preparations), API synthesis, food additives, medical device production, CMO processing, intermediate processing and other businesses. It is a national high-tech enterprise, a national science and technology business incubator, and a "specialized, special and new" enterprise in Beijing.

Jointown Pharmaceutical Group   www.jztey.com

We strive to be the most professional health service platform in China

As a technology-driven comprehensive service provider in the entire pharmaceutical chain, Jointown builds its business in the big health industry. The company's main business includes digital pharmaceutical distribution and supply chain business, general agency brand promotion business, pharmaceutical industry self-production and OEM business, new retail and 10,000 stores franchise business (C-end), medical health (C-end) and technology value-added services, digital logistics technology and supply chain solutions.

Jointown has taken the lead in the industry in implementing the transformation and upgrading from the traditional pharmaceutical distribution business to digitalization, platform and Internet, and has achieved remarkable results. From a single pharmaceutical distribution format to a pharmaceutical CSO, pharmaceutical new retail, pharmaceutical industry and other business formats gradually transformed and upgraded.

Jointown has built a scarce "100 billion-level" pharmaceutical supply chain service platform in the industry, completed the business layout of full-category procurement, omni-channel coverage and full-scene services, and relied on the resource advantages of the 100 billion platform to build the whole pharmaceutical industry chain and form a new pattern of integrated development of "pharmaceutical distribution + multi-format". Focusing on the six major business layouts, the company will further enhance its business growth points, and gradually form a large health comprehensive service platform that has significant characteristics such as multi-format and multi-platform in the industry, such as "batch and zero integration", "BC integration", and a combination of online and offline services for B-end and C-end users.

Recently, Jointown has vigorously promoted the implementation of the new strategy of "new products, new retail, new healthcare, digitalization and real estate securitization" (hereinafter referred to as "three new and two modernizations"), and the quality and efficiency of a number of characteristic business development have been continuously improved. With business innovation to drive growth, and digital management and control to improve quality and efficiency, Jointown insists on seeking progress while maintaining stability and opening a new situation.

In the future, Jointown will continue to implement the integrated service model of "pharmaceutical distribution + logistics distribution + product promotion", grasp the new market trend, take advantage of the trend, and maintain a steady growth trend.

Beijing Jingfeng Pharmaceutical Group Co.,ltd.

Beijing Jingfeng Pharmaceutical Group Co., Ltd. (Jingfeng Pharma), a wholly-owned subsidiary of Jointown Pharmaceutical Group, builds its business in the production and operation of the pharmaceutical industry, professional incubators and other health industries, generic drug research and development, FDF production (oral solid preparations, external semi-solid preparations, external liquid preparations), API synthesis, food additives, medical device production, CMO processing, intermediate processing and other businesses.

Main business

Pharmaceutical production, APIs, incubators, drug sales, drug research and development.

In the future, it will become a modern industrial enterprise with the most complete dosage forms, the most varieties, the best quality and the largest production capacity in China.

The company is located in the biomedical industry base of Zhongguancun Science and Technology Park, Daxing District, Beijing, which was completed in October 2017, covering an area of 106.20 acres, with a total investment of 700 million yuan, a total of 26 automatic production lines, and production equipment have reached the domestic advanced level. It has passed GMP certification on August 30, 2018 and has been officially put into production.

Other factories of Jingfeng Group
Our company has built production plants for Chinese patent medicines, chemical drugs and APIs in Daxing in Beijing, Tangshan in Hebei, Zibo in Shandong, Leshan in Sichuan

Hebei Feng Pharmaceutical

Beijing Jingfeng Pharmaceutical (Hebei) Co., Ltd. was established in June 2016 and is located in Fengnan District, Tangshan City, Hebei Province; In strict accordance with the national GMP standards, new hormone production workshops, non-hormone production workshops, sterile preparation workshops and high-end laboratories and other supporting facilities, including 10 non-hormone workshop tincture production lines, ointment production lines, cream production lines, and solution production lines.

Main business

Existing creams (including hormones), ointments (including hormones), tinctures (including hormones), solutions (including hormones), ointments, eye drops, gels and enemas, etc.

It has undertaken 20 advanced CMO and CDMO projects. It has obtained 17 domestic patents.

Shandong Toyotoshi Pharmaceutical

Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd. is located in Baita Industrial Park, Boshan District, Zibo City, in strict accordance with the national GMP standards to build a new preparation workshop, API workshop, power workshop, quality inspection center, environmental protection, noise reduction facilities and other auxiliary facilities, including more than 170 sets of preparation equipment, more than 20 sets of paste equipment, more than 50 sets of environmental protection equipment. In 2017, the GMP certification and environmental protection acceptance of all preparations and 4 varieties of APIs were completed, and all of them have now been put into production.

Main business

At present, there are 133 specifications and 25 special APIs in tablets (including cephalosporins), capsules (including cephalosporins), creams (including hormones), liniments, patches, ointments, gels and APIs. It covers the fields of psychiatric diseases, diabetes, antifungals, cardiovascular and cerebrovascular drugs, and antidotes. 

Sichuan Youhua Pharmaceutical

Youhua Pharmaceutical (Leshan) Co., Ltd. underwent asset restructuring and industrial and commercial changes, and officially changed its name and was listed in January 2016. The company has gradually developed into a pharmaceutical production enterprise integrating the R&D, production and sales of pharmaceutical raw materials, preparations, food additives and medical devices, with 105 varieties of Chinese medicine quasi-words, 1 variety of food additives and 1 variety of medical devices. Drugs include APIs and preparations, and the dosage forms include tablets, capsules, rods, ointments, creams, granules, and powders. The medical device is a disposable medical mask. The company is the only caffeine drug manufacturer in southwest China and the first medical mask manufacturer in Leshan.

Main business

Pharmaceutical production enterprises integrating the research and development, production and sales of pharmaceutical raw materials, preparations, food additives and medical devices. Pharmaceuticals include APIs and preparations, including tablets, capsules, rods, ointments, creams, granules, powders, etc.